Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Comparing screening methods for osteoporosis.

Jon Placide1, Mark G Martens

  • 1Department of Obstetrics/Gynecology, The University of Oklahoma, Tulsa, 1145 S. Utica, Suite 600, Tulsa, OK 74104, USA. mgmartens@aol.com

Current Women'S Health Reports
|May 8, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical challenges in diagnosis and treatment of recurrent vulvovaginal candidiasis.

SAGE open medicine·2022
Same author

Phase 3 study evaluating the safety and efficacy of oteseconazole in the treatment of recurrent vulvovaginal candidiasis and acute vulvovaginal candidiasis infections.

American journal of obstetrics and gynecology·2022
Same author

Probiotics: insights and new opportunities for <i>Clostridioides difficile</i> intervention.

Critical reviews in microbiology·2022
Same author

Hormone therapy in menopausal women with fibroids: is it safe?

Menopause (New York, N.Y.)·2018
Same author

Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study.

The Lancet. Infectious diseases·2016
Same author

Scorpion Envenomation in Pregnancy.

Southern medical journal·2016
Same journal

Ethics of research and the pregnant patient.

Current women's health reports·2003
Same journal

Medical education and indigent patient care.

Current women's health reports·2003
Same journal

Cloning and stem cells: processes, politics, and policy.

Current women's health reports·2003
Same journal

The impact of residents' work-hour restrictions.

Current women's health reports·2003
Same journal

Misoprostol in gynecology.

Current women's health reports·2003
Same journal

Sexuality during the perimenopause.

Current women's health reports·2003
See all related articles

Identifying osteoporosis risk is crucial. Dual-energy x-ray absorptiometry (DEXA) and calcaneal ultrasound effectively screen for fracture risk, with DEXA being most cost-effective for monitoring treatment progress.

Area of Science:

  • Osteoporosis screening and diagnosis
  • Bone health assessment
  • Medical imaging and diagnostics

Background:

  • Osteoporosis affects a significant, often undiagnosed, patient population.
  • Screening guidelines from organizations like the US Preventative Services Task Force and National Osteoporosis Foundation aim to identify at-risk individuals.
  • Effective screening requires tests that predict morbidity early, are accessible, and cost-effective.

Purpose of the Study:

  • To evaluate various screening methods for osteoporosis.
  • To identify the most effective and cost-efficient methods for predicting osteoporotic fractures.
  • To determine the optimal method for monitoring patients undergoing osteoporosis treatment.

Main Methods:

  • Review and examination of currently approved osteoporosis screening methods.

Related Experiment Videos

  • Assessment of test sensitivity and specificity in identifying patients at risk for osteoporotic fracture.
  • Comparative analysis of cost-effectiveness for screening and treatment monitoring.

    • Main Results:

    • Dual-energy x-ray absorptiometry (DEXA) and calcaneal ultrasound demonstrate strong predictive capabilities for identifying patients at risk of fracture.
    • DEXA is identified as the most cost-effective method for monitoring bone mineral changes in patients undergoing treatment due to the long-term nature of demonstrating these changes.

    Conclusions:

    • DEXA and calcaneal ultrasound are leading methods for osteoporosis risk assessment.
    • DEXA offers the best cost-effectiveness for long-term patient monitoring during osteoporosis treatment.